O'Connor KC - Search Results

1

Novel pathophysiological insights in autoimmune myasthenia gravis.

Masi G, O'Connor KC. Masi G, et al. Curr Opin Neurol. 2022 Oct 1;35(5):586-596. doi: 10.1097/WCO.0000000000001088. Epub 2022 Aug 4. Curr Opin Neurol. 2022. PMID: 35942663 Free PMC article. Review.

2

Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.

Keung B, Robeson KR, DiCapua DB, Rosen JB, O'Connor KC, Goldstein JM, Nowak RJ. Keung B, et al. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1407-9. doi: 10.1136/jnnp-2012-303664. Epub 2013 Jun 12. J Neurol Neurosurg Psychiatry. 2013. PMID: 23761915 No abstract available.

3

Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.

Cao Y, Amezquita RA, Kleinstein SH, Stathopoulos P, Nowak RJ, O'Connor KC. Cao Y, et al. J Immunol. 2016 Mar 1;196(5):2075-84. doi: 10.4049/jimmunol.1501339. Epub 2016 Jan 29. J Immunol. 2016. PMID: 26826242 Free PMC article.

4

Current and future immunotherapy targets in autoimmune neurology.

Hu MY, Stathopoulos P, O'connor KC, Pittock SJ, Nowak RJ. Hu MY, et al. Handb Clin Neurol. 2016;133:511-36. doi: 10.1016/B978-0-444-63432-0.00027-X. Handb Clin Neurol. 2016. PMID: 27112694 Review.

5

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.

Lee JY, Stathopoulos P, Gupta S, Bannock JM, Barohn RJ, Cotzomi E, Dimachkie MM, Jacobson L, Lee CS, Morbach H, Querol L, Shan JL, Vander Heiden JA, Waters P, Vincent A, Nowak RJ, O'Connor KC. Lee JY, et al. Ann Clin Transl Neurol. 2016 Apr 27;3(6):443-54. doi: 10.1002/acn3.311. eCollection 2016 Jun. Ann Clin Transl Neurol. 2016. PMID: 27547772 Free PMC article.

6

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody-Positive Myasthenia Gravis.

Robeson KR, Kumar A, Keung B, DiCapua DB, Grodinsky E, Patwa HS, Stathopoulos PA, Goldstein JM, O'Connor KC, Nowak RJ. Robeson KR, et al. JAMA Neurol. 2017 Jan 1;74(1):60-66. doi: 10.1001/jamaneurol.2016.4190. JAMA Neurol. 2017. PMID: 27893014

7

Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing.

Vander Heiden JA, Stathopoulos P, Zhou JQ, Chen L, Gilbert TJ, Bolen CR, Barohn RJ, Dimachkie MM, Ciafaloni E, Broering TJ, Vigneault F, Nowak RJ, Kleinstein SH, O'Connor KC. Vander Heiden JA, et al. J Immunol. 2017 Feb 15;198(4):1460-1473. doi: 10.4049/jimmunol.1601415. Epub 2017 Jan 13. J Immunol. 2017. PMID: 28087666 Free PMC article.

8

B cells in the pathophysiology of myasthenia gravis.

Yi JS, Guptill JT, Stathopoulos P, Nowak RJ, O'Connor KC. Yi JS, et al. Muscle Nerve. 2018 Feb;57(2):172-184. doi: 10.1002/mus.25973. Epub 2017 Sep 30. Muscle Nerve. 2018. PMID: 28940642 Free PMC article. Review.

9

Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis.

Stathopoulos P, Kumar A, Heiden JAV, Pascual-Goñi E, Nowak RJ, O'Connor KC. Stathopoulos P, et al. Ann N Y Acad Sci. 2018 Jan;1412(1):154-165. doi: 10.1111/nyas.13535. Ann N Y Acad Sci. 2018. PMID: 29381221 Free PMC article. Review.

10

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.

Takata K, Stathopoulos P, Cao M, Mané-Damas M, Fichtner ML, Benotti ES, Jacobson L, Waters P, Irani SR, Martinez-Martinez P, Beeson D, Losen M, Vincent A, Nowak RJ, O'Connor KC. Takata K, et al. JCI Insight. 2019 Jun 20;4(12):e127167. doi: 10.1172/jci.insight.127167. eCollection 2019 Jun 20. JCI Insight. 2019. PMID: 31217355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page